Dermatology Medical News about Cosmeceuticals

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cosmeceuticals: undefined, unclassified, and unregulated
Clinics in Dermatology, 08/28/09

Draelos ZD – In the United States, cosmeceuticals are sold as cosmetics, making marketing, packaging, and aesthetic appeal important considerations. Ideally, the cosmeceutical should be clinically tested for efficacy to ensure a proven skin benefit and also to substantiate marketing claims. Governmental limitations of efficacy claims restrict cosmeceutical development because products can only be assessed in terms of their ability to improve skin appearance but not function. Improving function would remove the cosmeceutical from the cosmetic category and place it in the drug category. Herein lies the challenge of defining the cosmeceutical category.

<< Previous
Immunotherapy with Wasp Venom is Accompanied by Wide-ranging...

Next >>
Foot or hand malformations related to deep venous system...

The contribution of neurogenic inflammation to sensitive skin: concepts, mechanisms and cosmeceutical intervention
International Journal of Cosmetic Science, 11/03/09 Relevance Score: 89%